Abstract:
: ob<x>jective: To investigate the ex<x>pression and clinical significance of miRNA-182-5p (miR-182-5p) and three-domain protein 8 (TRIM8) in endometrial carcinoma. Methods: A total of 76 patients with endometrial cancer who underwent surgical treatment in Xuzhou Central Hospital from January 2015 to June 2016 were selected. The surgically removed endometrial cancer tissues and corresponding adjacent tissues were collected, and the ex<x>pression level of TRIM8 protein in the tissues was detected by immunohistochemical method.The mRNA ex<x>pression levels of Mir-182-5p and TRIM8 were detected by QRT-PCR, correlation analysis was performed by Spearman method, and prognostic factors of endometrial cancer were analyzed by Kaplan-Meier method and Cox proportional risk regression model. Results: Immunohistochemical results showed that the positive ex<x>pression rate of TRIM8 protein in endometrial cancer tissues (55.26%) was lower than that in adjacent tissues (73.68%) (P < 0.05). QRT-PCR results showed that the ex<x>pression level of miR-182-5p in endometrial cancer tissues was significantly higher than that in adjacent tissues.The ex<x>pression level of TRIM8 was significantly lower than that of adjacent tissues (P < 0.05).The ex<x>pression levels of miR-182-5p and TRIM8 in endometrial cancer tissues were correlated with FIGO stage and lymph node me<x>tastasis (P < 0.05).Spearman correlation analysis showed that miR-182-5p was negatively correlated with THE ex<x>pression level of TRIM8 (r=-0.575, P < 0.05).Kaplan- meier analysis showed that patients with high Mir-182-5P ex<x>pression and low TRIM8 ex<x>pression had a poor prognosis (P < 0.05).Cox multivariate regression analysis showed that miR-182-5p and TRIM8 were independent risk factors affecting the prognosis of patients with endometrial cancer. Conclusion: The ex<x>pression of miR-182-5p is up-regulated and the ex<x>pression of TRIM8 is down-regulated in endometrial cancer tissue. The dysregulation of miR-182-5p and TRIM8 may be involved in the occurrence and development of endometrial cancer, and is expected to become a potential biomarker for the diagnosis, treatment and prognosis assessment of endometrial cancer.